Tempus AI (TEM) lies at the core of the healthcare revolution. It uses AI to turn medical data into practical insights to ...

Tempus announced its acquisition of Ambry Genetics at closing in November and the deal closed earlier this month.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will present at the TD Cowen 45th Annual Health Care Conference on March ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley Technology, Media & Telecom ...

Tempus AI, Inc. Class A (TEM – Research Report) received a Hold rating and price target from William Blair analyst Andrew Brackmann today. The company’s shares closed yesterday at $89.44 ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other health information services stocks. Health Information Services stocks have become a key ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against other firms that posted double-digit gains on Thursday. Wall Street’s main indices finished in ...

Empowered Funds LLC raised its holdings in shares of VOXX International Co. (NASDAQ:VOXX – Free Report) by 5.1% in the fourth ...

This section features announcements of construction project activity or other legal notices received from the public and private sector. Included are projects in the hard-bid stage, projects in ...

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough. You can follow him investing $500,000 of his own money on our top AI stocks for free.

One of the first actions by GSK's recently appointed chief scientific officer, Tony Wood, has been to expand a partnership with Tempus aimed ... group to tap into that resource, with the aim ...